MRNA Jan 2024 110.000 call
| Previous close | 86.50 |
| Open | 86.50 |
| Bid | 83.20 |
| Ask | 87.55 |
| Strike | 110.00 |
| Expiry date | 2024-01-19 |
| Day's range | 86.50 - 86.50 |
| Contract range | N/A |
| Volume | |
| Open interest | 49 |
- Editor's pickYahoo Finance Video
Stocks gaining in early trading: Nvidia, AMD, Tesla, Moderna, Gilead
Yahoo Finance Live’s Brad Smith breaks down how stocks are moving in early trading.
- Bloomberg
UK Takes World’s First Step Toward Omicron-Tailored Shot
(Bloomberg) -- Most Read from BloombergSaudi Billionaire Made $500 Million Russia Bet at War OnsetWells Fargo Plans Major Retreat From Mortgage Business It Long DominatedWill Housing Prices Flatten — or Collapse?How the US Toppled the World’s Most Powerful Gold TraderUkraine Latest: First UN Wheat Cargo Sets Sail for EthiopiaThe UK has granted the world’s first approval for a Covid-19 vaccine targeting a variant in a bid to sharpen its response to an evolving coronavirus. The country’s Medicines
- Zacks
Novavax's (NVAX) COVID Vaccine Aids Growth, Overdependence Ails
Currently, Novavax (NVAX) has only one marketed product in its portfolio, its protein-based COVID-19 vaccine. However, it is lagging in competition behind mRNA-based vaccines.
